Principal Financial Group Inc Gossamer Bio, Inc. Transaction History

Principal Financial Group Inc

$184 Billion
Q3 2025

A detailed history of Principal Financial Group Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 14,578 shares of GOSS stock, worth $39,506. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,578

Previous 13,508 7.92%

Holding current value

$39,506

Previous $16,000 137.5%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	BUY	$1.21 - $3.46 $1,294 - $3,702	1,070 Added 7.92%	14,578 $38,000
Q2 2025 Aug 08, 2025	BUY	$0.78 - $1.44 $10,536 - $19,451	13,508 New	13,508 $16,000
Q1 2024 Apr 29, 2024	SELL	$0.8 - $1.51 $3,686 - $6,958	-4,608 Reduced 13.34%	29,935 $35,000
Q4 2023 Feb 07, 2024	BUY	$0.48 - $1.08 $498 - $1,122	1,039 Added 3.1%	34,543 $31,000
Q2 2023 Aug 07, 2023	BUY	$0.98 - $1.53 $12,105 - $18,900	12,353 Added 58.4%	33,504 $40,000

Q1 2023 May 09, 2023	SELL	$0.96 - $2.92 $1,314 - $3,997	-1,369 Reduced 6.08%	21,151 $26,000
Q4 2022 Feb 09, 2023	BUY	$1.74 - $12.87 $7,849 - $58,056	4,511 Added 25.05%	22,520 $48,000
Q3 2022 Nov 09, 2022	SELL	$7.21 - $14.88 $2,465 - $5,088	-342 Reduced 1.86%	18,009 $216,000
Q2 2022 Aug 10, 2022	BUY	$5.97 - $9.97 $109,555 - $182,959	18,351 New	18,351 $154,000
Q4 2021 Feb 09, 2022	SELL	$10.12 - $14.07 $151,810 - $211,064	-15,001 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$7.25 - $13.23 $17,653 - $32,215	-2,435 Reduced 13.97%	15,001 $189,000
Q2 2021 Aug 10, 2021	BUY	$8.0 - $9.75 $4,688 - $5,713	586 Added 3.48%	17,436 $141,000
Q1 2021 May 10, 2021	BUY	$8.63 - $10.94 $10,226 - $12,963	1,185 Added 7.56%	16,850 $156,000
Q4 2020 Feb 08, 2021	BUY	$8.3 - $13.59 $18,500 - $30,292	2,229 Added 16.59%	15,665 $151,000
Q3 2020 Nov 06, 2020	SELL	$11.3 - $14.75 $7,503 - $9,794	-664 Reduced 4.71%	13,436 $166,000
Q2 2020 Aug 05, 2020	BUY	$9.52 - $15.98 $37,318 - $62,641	3,920 Added 38.51%	14,100 $183,000
Q1 2020 May 12, 2020	BUY	$8.0 - $15.48 $81,440 - $157,586	10,180 New	10,180 $103,000

Others Institutions Holding GOSS

# of Institutions

181

Shares Held

163M

Call Options Held

8.11M

Put Options Held

211K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $255M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Gossamer Bio, Inc. Transaction History